Skip to main content
Clinical Trials/NCT01522482
NCT01522482
Completed
Not Applicable

Effects of Meal Fatty Acid Composition on Postprandial Lipaemia in Men According to APOE Genotype

University of Reading1 site in 1 country31 target enrollmentMarch 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Disease
Sponsor
University of Reading
Enrollment
31
Locations
1
Primary Endpoint
Impact of APOE genotype and dietary fat composition in plasma lipids
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

Cardiovascular disease (CVD) is the greatest cause of morbidity and mortality in the UK. Abnormalities in the concentration and/or composition of lipoproteins (the lipid carrying particles), in particular low density lipoproteins (LDL) in circulation, is one of the most important physiological defects contributing to the development of CVD.

The LDL cholesterol (LDLC) response to fatty acid change is in part mediated by the APOE genotype, with E4 individuals (25% of the UK population) being most responsive to changes in dietary fats, showing greater reductions when low levels of saturated fats or fish oils are consumed and greater increases when high levels of these fats are consumed. Therefore the aims of the present study is to understand the mechanism that regulates the higher LDLC response associated with saturated fatty acids and fish oil consumption in healthy men prospectively recruited based on their APOE genotype.

Registry
clinicaltrials.gov
Start Date
March 2009
End Date
July 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Julie Lovegrove

Professor

University of Reading

Eligibility Criteria

Inclusion Criteria

  • Gender Male
  • Age 18-70 years
  • Body Mass Index (BMI) \< 32 kg/m2
  • Plasma triglycerides 1-4 mmol/l
  • Plasma cholesterol \< 8 mmol/l
  • Glucose \< 7 mmol/l
  • Haemoglobin \> 11 g/dl
  • ApoE E3/E3, E3/E4

Exclusion Criteria

  • Blood pressure \> 200/95 mmHg
  • Had suffered a myocardial infraction or stroke in previous 2 years.
  • Diabetes mellitus
  • Liver disease
  • Other endocrine disorders
  • Unstable angina
  • Familial hyperlipidaemia
  • Any dietary restrictions or an a weight reducing diet
  • On fatty acid supplements e.g. evening primrose oil or fish oils
  • Vigorous exercise e.g. competitive athletes

Outcomes

Primary Outcomes

Impact of APOE genotype and dietary fat composition in plasma lipids

Time Frame: 3 months

Secondary Outcomes

  • Cardiovascular disease risk factors(3 months)

Study Sites (1)

Loading locations...

Similar Trials